TXG
10X Genomics Inc
NASDAQ: TXG · HEALTHCARE · HEALTH INFORMATION SERVICES
$22.05
+9.16% today
Updated 2026-04-30
Market cap
$2.61B
P/E ratio
—
P/S ratio
4.05x
EPS (TTM)
$-0.35
Dividend yield
—
52W range
$8 – $26
Volume
2.4M
10X Genomics Inc (TXG) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
7 of 8
Last 8 quarters
Avg EPS surprise
+107.7%
Last 4 quarters
Revenue YoY growth
+0.6%
Most recent quarter
EPS YoY growth
+150.4%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-4.5%
Last 3 reports
Positive reaction rate
0%
0 of 3 quarters
Largest single-day move
-5.4%
2026-02-12
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-12 | $0.07 | +132.5% | $19.15 | $18.12 | -5.4% |
| 2025-10-28 | $-0.02 | +67.4% | $13.59 | $12.90 | -5.1% |
| 2025-08-07 | $0.28 | +190.3% | $12.66 | $12.29 | -2.9% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.22 | $0.07 | +132.5% | $166.03M | +0.6% |
| 2025-09-30 | $-0.07 | $-0.02 | +67.4% | $149.00M | -1.7% |
| 2025-06-30 | $-0.31 | $0.28 | +190.3% | $172.91M | +12.9% |
| 2025-03-31 | $-0.47 | $-0.28 | +40.4% | $154.88M | +9.8% |
| 2024-12-31 | $-0.11 | $-0.14 | -27.3% | $165.02M | -10.3% |
| 2024-09-30 | $-0.26 | $-0.02 | +92.3% | $151.65M | -1.3% |
| 2024-06-30 | $-0.48 | $-0.32 | +33.3% | $153.10M | +4.3% |
| 2024-03-31 | $-0.50 | $-0.50 | +0.0% | $141.01M | — |
| 2023-12-31 | $-0.36 | $-0.41 | -13.9% | $183.98M | — |
| 2023-09-30 | $-0.46 | $-0.79 | -71.7% | $153.64M | — |
| 2023-06-30 | $-0.40 | $-0.53 | -32.5% | $146.82M | — |
Frequently asked questions
Has 10X Genomics Inc beaten earnings estimates?
10X Genomics Inc has beaten Wall Street EPS estimates in 7 of its last 8 quarterly reports, with an average EPS surprise of +107.7% over the last 4 quarters.
How does TXG stock react to earnings?
TXG stock has moved an average of -4.5% in the trading day following earnings over its last 3 reports, with positive reactions in 0% of those quarters.
What is 10X Genomics Inc's revenue growth rate?
10X Genomics Inc reported year-over-year revenue growth of +0.6% in its most recent quarter, with EPS growing +150.4% year-over-year.